PharmaShots

MARCH 31, 2023

Shots: The companies collaborated to evaluate the safety, tolerability, PK, PD & preliminary antitumor activity of OTX-2002 as monotx. The preliminary results from the monotx.

Immunity 40

Immunity Immunization 40

Express Pharma

MARCH 18, 2023

As per the latest update, CCI has given its approval to the proposed combination under sub-section (1) of Section 31 of the Competition Act, 2002 vide its letter dated March 15, 2023. The detailed order of CCI is awaited.

97

97

Express Pharma

NOVEMBER 1, 2023

Since 2002, Science has been studying the best organisations in biotech, pharma, and biopharma as part of its Top Employers Survey. Based in the United States, Science is the peer-reviewed academic journal of the American Association for the Advancement of Science (AAAS) and one of the world’s top academic journals.

115

115

ALiEM - Pharm Pearls

FEBRUARY 16, 2024

2002), Role of sonography in the diagnosis of gallbladder perforation. 1983 Jul;148(1):219-21. doi: 10.1148/radiology.148.1.6856839. 148.1.6856839. PMID: 6856839. Khandelwal, N. and Suri, S. Ultrasound, 30: 270-274.

Hospitals 161

Hospitals 161

Pharma Pathway

JANUARY 31, 2023

BDR Pharmaceuticals- Openings for Production/ QA/ QC/ CVC/ Packing/ Engineering- Apply Now Job Description BDR Pharmaceuticals was Established in 2002 into API manufacturing, We have a consolidated position in the domestic and global market for the API Business.

83

83

pharmaphorum

DECEMBER 14, 2022

Sodium oxybate — which in the late 1980s was marketed to bodybuilders and then became known as GHB and criminally used as a date rape drug — has been sold under the brand name Xyrem after gaining FDA approval in 2002. That’s an objectively long time to have exclusivity of a drug that was first synthesised nearly 100 years ago.

Controlled Substances 116

Controlled Substances 116

Express Pharma

OCTOBER 25, 2024

based peer-reviewed journal of the American Association for the Advancement of Science (AAAS), has conducted this Top Employers Survey annually since 2002, evaluating the leading organisations in the biotech, pharma, and biopharma fields. Science , a U.S.-based

105

105

Pharma Pathway

FEBRUARY 23, 2023

BDR Pharmaceuticals-Walk-In Drive for Production/ QA/ QC/ ADL/ Engineering On 25th Feb’ 2023 Job Description BDR Pharmaceuticals was Established in 2002 into API manufacturing, We have a consolidated position in the domestic and global market for the API Business.

78

78

European Pharmaceutical Review

AUGUST 4, 2023

billion in 2022, a product that was launched in 2002. There are at present, nine US Food and Drug Administration (FDA)-approved agents, GlobalData stated. Worldwide sales for Humira peaked at $21.2 percent in the first quarter compared to the same time last year.

Biosimilars 97

Biosimilars 97

Big Molecule Watch

SEPTEMBER 6, 2024

10405–10410 (2002) (“Xie”), Stephen Snowdy, Nuclear targeting by adeno-associated virus capsid proteins and virions (2003) (Ph.D. The PTAB now has granted institution of Sarepta’s IPR, which challenges claims 1, 3-6, and 8 of the ’274 patent as obvious over four prior art references: US 2003/0138772 A1 (“’772 Publication”), Qing Xie et al.,

49

49

pharmaphorum

AUGUST 7, 2024

In 2002, Dr Barton founded PharmaVision to provide independent, tailor-made, life sciences, and consumer health research to pharmaceutical companies, competitive intelligence specialists, investment institutions, and healthcare communication agencies.

Communication 52

Communication Pharmaceutical Companies Pharmaceutical Companies 52

Pharma Marketing Network

JULY 27, 2022

Reach out at swhite@xaviercreative.com. Connect at linkedin.com/in/sunnywhite/ . REFERENCES: Organization, World Health. The IMPORTANCE of PHARMACOVIGILANCE Safety Monitoring of Medicinal Products. Accessed June 18, 2022. The post Personalizing the Cancer Patient Journey appeared first on Pharma Marketing Network.

Communication 130

Communication 130

European Pharmaceutical Review

DECEMBER 1, 2022

GlobalData stated that if development is successful for Ultragenyx’s OTX-2002 , which has potential to be the first programmable epigenetic medicine, it could generate $1.6 billion during 2028.

Vaccines 98

Vaccines Immunity Immunization 98

Pharmaceutical Technology

MAY 15, 2023

In a 2002 WHI study, patients treated with oestrogen and progesterone were reported to have a significantly higher risk of stroke, heart attacks and breast cancer. This includes an increased risk of heart attack, stroke, and breast cancer, amongst others, per the US National Institutes of Health’s National Institute on Aging.

97

97

Express Pharma

MAY 29, 2024

From its 2002 FDA approval to 2023, Humira generated $187 billion for AbbVie. These products are forecast to collectively generate over $32 billion by 2030, enabling AbbVie to financially rebound and continue its position as a leading immunology player, says GlobalData.

Biosimilars 101

Biosimilars 101

pharmaphorum

SEPTEMBER 28, 2021

GlaxoSmithKline (then SmithKline Beecham) developed a Lyme disease vaccine called Lymerix back in the 1990s, but it fell foul of anti-vaccine sentiment and the drugmaker eventually pulled it off the market in 2002, after settling a class action lawsuit claiming injuries from side effects.

Vaccines 105

Vaccines 105

Safe Biologics

SEPTEMBER 27, 2024

Department of Health and Human Services from 2002-2008, including three years as Associate Deputy Secretary. A failure to do so will put patient health outcomes, and physician trust in these important medicines, in jeopardy. Michael Reilly served in the Office of the Secretary of the U.S. Read the oped at RealClearHealth

Biosimilars 100

Biosimilars 100

Express Pharma

AUGUST 1, 2023

Humira has long been a very profitable asset for AbbVie, with steadily rising annual US sales since its launch in 2002; peaking at $18.6 Against this backdrop, Cyltezo from Boehringer Ingelheim has shown the intersection of price and regulation in the biosimilar market, says GlobalData. billion in 2022 ($21.2 billion global).

Biosimilars 98

Biosimilars 98

European Pharmaceutical Review

JULY 25, 2022

The new Regulation will replace the rules for safety and quality set out in Directives 2002/98/EC for blood and blood components and 2004/23/EC for tissues and cells, in addition to their implementing acts. .

116

116

pharmaphorum

FEBRUARY 9, 2022

Established in 2002, we have a deep heritage and expertise in healthcare strategy and communication, and we continue to learn and grow in the fast-changing healthcare sphere. AXON has an international reach, with offices in Copenhagen, London, New York, and Toronto, and a worldwide affiliate network.

Communication 98

Communication 98

pharmaphorum

MARCH 2, 2022

” Established in 2002, Argon Global Healthcare has built a global healthcare agency network covering major markets in EMEA, Americas, and APAC. This robust network comprises independently owned healthcare communications agencies with a proven track record of high performance.

Communication 64

Communication 64

pharmaphorum

AUGUST 19, 2020

Founded by Hallows and Brian Parsons in 2002, the Reading, UK-headquartered Porterhouse is a healthcare communications and insights research agency that provides scientific and medical expertise to the global pharmaceutical industry.

Communication 59

Communication 59

pharmaphorum

AUGUST 17, 2021

Established in 2002, AXON is an AVENIR GLOBAL company. Our expertise includes medical communications, public relations, clinical trial services and market access communications services/consultancy for pharmaceutical, biotech, medical device, animal health and functional food companies. About AVENIR GLOBAL.

Communication 98

Communication 98

Express Pharma

OCTOBER 4, 2024

MNI’s unique plant-based formulations, developed in 2002 by a team of healthcare professionals, have been extensively tested to ensure their efficacy.” Mariaan du Plessis, CEO of MNI , shared her excitement about joining Pharma Dynamics. “We

Diabetes 52

Diabetes Immunity Immunization 52

RX Note

MARCH 31, 2024

Effect of melatonin on tinnitus, 1998 The role of zinc in management of tinnitus, 2002 Ginkgo biloba for tinnitus, 2013 Zinc supplementation for tinnitus, 2016 Ginkgo biloba for tinnitus, 2022 External Links Effect of melatonin on tinnitus, 1998 A meta-analytic review of psychological treatments for tinnitus, 1999 The role of zinc in management of (..)

Community Pharmacies 52

Community Pharmacies 52

PharmaShots

APRIL 3, 2023

REGiMMUNE’s RGI-2001 is currently in P-III trial for the prophylaxis of aGVHD Ref: Businesswire | Image: Regimmune Related News:- Omega Therapeutics Entered into a Clinical Supply Agreement with Roche to Evaluate OTX-2002 for Hepatocellular Carcinoma

40

40

pharmaphorum

MAY 30, 2022

” Cialis (tadalafil) is sold as a prescription-only therapy worldwide for ED, and was first approved for marketing in 2002, reaching sales of $2.3 .” According to the French pharma group the study has not yet recruited any patients, and it will “engage the agency in upcoming meetings as we determine next steps.”

59

59

PharmaState Academy

FEBRUARY 8, 2024

Do This and No Matter Where You Are, You Will Have Nothing To Fear.” – The Cat Returns (2002) Note: You can participate only 1 time. "Always Believe In Yourself. Participation by using another name & email id will lead to disqualification. The winner will be announced after profile verification.

52

52

Pharmaceutical Technology

AUGUST 17, 2022

A vaccine called Lymerix , then manufactured by SmithKline Beecham, was approved in the US in 1998 but was quickly withdrawn in 2002 due to insufficient custo mer demand. Lyme disease is also known as borreliosis, which refers to the borrelia bacteria that cause the condition. It is currently treated with antibiotics.

Vaccines 119

Vaccines 119

Eye on FDA

AUGUST 2, 2022

By 2002, the number had dropped to 28, reviving somewhat by the end of that decade when it reached 52 in 2010. But when it comes to enforcement things have changed greatly over the years. In 1998, there were 156 letters issued in a single year.

Communication 88

Communication Pharmaceutical Companies Pharmaceutical Companies Documentation 88

pharmaphorum

FEBRUARY 18, 2021

6 The stakes were extremely high, with annual costs of insulin reaching $736 per patient in 2013, up threefold since 2002. RESULT: As of 2002, 40% of PRILOSEC patients had switched to NEXIUM, which notched up sales of $3.9 Eli Lilly’s Humalog compound and formulation patents expired in 2013 and 2014, respectively. billion in 2004.14

Prescription Filling 52

Prescription Filling Drug Pricing Biosimilars Compounding 52

RX Note

NOVEMBER 3, 2023

, 2000 Tolerability of ibuprofen, aspirin and paracetamol for the treatment of cold and flu symptoms and sore throat pain, 2002 Local anaesthetic properties of ambroxol hydrochloride lozenges in view of sore throat. Clinical proof of concept, 2002 Flurbiprofen: new indication. Lozenges: NSAIDs are not to be taken like sweets!,

Immunity 40

Immunity Immunization Community Pharmacies 40

European Pharmaceutical Review

SEPTEMBER 14, 2023

2 By comparison, the American Society of Health-System Pharmacists (ASHP) identified only 224 drug shortages during the entire six-year period between January 1996 and June 2002. EMA prepares for winter antibiotic shortages That slowdown resulted in 211 drug shortages in 2010—the highest number recorded in a single year at the time.

Drug Development 98

Drug Development Drug Pricing Communication 98

FDA Law Blog: Biosimilars

JUNE 11, 2023

Between 2002 and 2019, there were 768 products with pediatric labeling changes under BPCA and/or PREA. However, given FDA’s prior announced policy, it is somewhat surprising that only 16% of pediatric labeling changes pursuant to BPCA and/or PREA between 2002 and 2019 were conducted under both the BPCA and PREA.

Labelling 40

Labelling Drug Development 40

pharmaphorum

AUGUST 24, 2022

.” Indivior paid $600 million to settle criminal fraud charges of improper marketing of Suboxone in 2020, and last year agreed another payment of $300 million to resolve civil claims brought by US states.

52

52

Pharma in Brief

OCTOBER 28, 2021

Nikolaisen , 2002 SCC 33. [2] The FCA remitted the matter to the FC to: determine what information, if any, was exempt from disclosure only under paragraph 20(1)(d); determine if the “Identity of suppliers” is exempt from disclosure; and. Costs were awarded to Elanco. Canada (Health) v. Elanco Canada Limited , 2021 FCA 191. [1] 1] Housen v.

Documentation 52

Documentation 52

pharmaphorum

APRIL 4, 2022

Established in 2002, we have a deep heritage and expertise in healthcare strategy and communication, and we continue to learn and grow in the fast-changing healthcare sphere. AXON has an international reach, with offices in Copenhagen, London, New York, and Toronto, and a worldwide affiliate network.

Communication 59

Communication 59